936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
    Journal Article

    Shiuan, E.; Beckermann, K. E.; Ozgun, A.; Kelly, C.; McKean, M.; McQuade, J.; Thompson, M. A.; Puzanov, I.; Greer, J. P.; Rapisuwon, S.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: A pooled analysis
    Journal Article

    D'Angelo, S. P.; Larkin, J.; Sosman, J. A.; Lebbé, C.; Brady, B.; Neyns, B.; Schmidt, H.; Hassel, J. C.; Hodi, F. S.; Lorigan, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I/randomized phase II study of MLN0128 v.s pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304
    Meeting Abstract

    Tap, W. D.; Mahoney, M. R.; Jaslowski, A. J.; Horvath, L. E.; Schwartz, G.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): Results of SARCO28 - A multicenter phase II study
    Meeting Abstract

    Tawbi, H. A. H.; Burgess, M. A.; Crowley, J.; Van Tine, B. A.; Hu, J.; Schuetze, S.; D'Angelo, S. P.; Attia, S.; Priebat, D. A.; Okuno, S. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy of sorafenib in patients with desmoid-type fibromatosis
    Meeting Abstract

    Munhor, R. R.; Lefkowitz, R. A.; Kuk, D.; Dickson, M. A.; D'Angelo, S. P.; Keohan, M. L.; Chi, P.; Crago, A. M.; Maki, R. G.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cytokine release syndrome (CRS) in patients treated with NY-ESO-1(c259) TCR
    Meeting Abstract

    Mackall, C.; D'Angelo, S. P.; Cristea, M. C.; Odunsi, K.; Norry, E.; Pandite, L.; Holdich, T.; Kari, G.; Ramachandran, I. R.; Ribeiro, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Autologous genetically engineered NY-ESO-1(c259)T in HLA-A*02:01, HLA*02:05 and HLA*02:06 positive patients with NY-ESO-1 expressing tumors
    Meeting Abstract

    Mackall, C.; D'Angelo, S. P.; Grupp, S. A.; Odunsi, K.; Cristea, M. C.; Linette, G. P.; Kluger, H. M.; Kari, G.; Pandite, L.; Holdich, T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic Merkel cell carcinoma previously treated with chemotherapy: Results of the phase 2 JAVELIN Merkel 200 trial
    Meeting Abstract

    Kaufman, H.; Russell, J. S.; Hamid, O.; Bhatia, S.; Terheyden, P.; D'Angelo, S. P.; Shih, K. C.; Lebbe, C.; Linette, G. P.; Milella, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Retrospective review of subsequent treatments (tx) for esophagogastric adenocarcinomas (EGA) refractory to FOLFOX
    Meeting Abstract

    Kelly, C. M.; Janjigian, Y. Y.; Kelsen, D. P.; Capanu, M.; Chou, J. F.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Outcomes of systemic therapy for patients with metastatic undifferentiated pleomorphic sarcoma (UPS)
    Meeting Abstract

    Adrianzen Herrera, D. A.; Kuk, D.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Agaram, N. P.; Antonescu, C. R.; Hameed, M.; Tap, W. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save